Evaluasi Kesesuaian Penggunaan Antbiotik pada Pasien dengan Infeksi Methicillin Resistant Staphylococcus Aureus (MRSA)  di RSUD. Dr. Moewardi Surakarta

Tristina Devi Azzahra; Titik Nuryastuti; Ika Puspitasari

doi:10.22146/farmaseutik.v16i2.48025

Evaluasi Kesesuaian Penggunaan Antbiotik pada Pasien dengan Infeksi Methicillin Resistant Staphylococcus Aureus (MRSA) di RSUD. Dr. Moewardi Surakarta

https://doi.org/10.22146/farmaseutik.v16i2.48025

Tristina Devi Azzahra⁽¹⁾, Titik Nuryastuti⁽²⁾, Ika Puspitasari^(3*)

(1) Magister Farmasi Klinik, Fakultas Farmasi, UGM
(2) Departemen Mikrobiologi, FKKMK, UGM
(3) Faculty of Pharmacy, Universitas Gadjah Mada
(*) Corresponding Author

Abstract

MRSA is one of the Multi Drug Resistant Organism (MDRO) with a high number of cases and problem. Incidence of MRSA in Indonesia is quite significant every years. In 1986 there were 2.5%, 1993 increased to 9.4% and in 2006 23.5%. The problem is methicillin is no longer effective and other antibiotics vary in efficacy. The aims of this reasearch was to evaluate the used of antibiotics in patients with MRSA infection in Dr. Moewardi Hospital in Surakarta. The study was performed using retrospective Cohort study to examine the relationship between suitability antibiotic to clinical outcomes in patients with MRSA infection in Dr. Moewardi Hospital in Surakarta during period 1 January 2017 - 31 December 2018. The evaluation was conducted to the suitability of type, dose, frequency, duration of antibiotic use and pharmacokinetic profile. Chi-square test was used to analyse the relationship of antibiotic suitability to clinical outcomes including predicted pharmacokinetic parameters for clinical outcomes.

There were 28 samples with MRSA infection tested in this study. Twenty one patients (75%) used appropriate antibiotics showed good clinical outcome 21 patients (85,7%) and 7 patients (25%) with unsuitable antibiotics showed good clinical outcome 71,4%.

Keywords: antibiotic, clinical outcome, pharmacokinetic, MRSA.

Full Text:

PDF

References

DAFTAR PUSTAKA

Amalia, B. dan Saharman, Y.R., 2012. Kejadian Kolonisasi Methicillin-Resistant Staphylococcus Aureus (MRSA) dan Hubungannya dengan Riwayat Rawat Sebelum Masuk ICU pada Pasien ICU PUSAT RSCM Tahun 2011.

Chen, C. dan Huang, Y., 2014. New epidemiology of Staphylococcus aureus infection in Asia.

Cosgrove, S.E., 2006. The Relationship between Antimicrobial Resistance and Patient Outcomes: Mortality, Length of Hospital Stay, and Health Care Costs. Clinical Infectious Diseases, 42: S82–S89.

Crandon, J.L., Kim, A., dan Nicolau, D.P., 2009. Comparison of tigecycline penetration into the epithelial lining fluid of infected and uninfected murine lungs. Journal of Antimicrobial Chemotherapy, 64: 837–839.

Datta, P., Gulati, N., Singla, N., Rani Vasdeva, H., Bala, K., Chander, J., dkk., 2011. Evaluation of various methods for the detection of meticillin-resistant Staphylococcus aureus strains and susceptibility patterns. Journal of Medical Microbiology, 60: 1613–1616.

Erikawati, D., Santosaningsih, D., dan Santoso, S., 2016. Tingginya Prevalensi MRSA pada Isolat Klinik Periode 2010- 2014 di RSUD Dr. Saiful Anwar Malang, Indonesia. Jurnal Kedokteran Brawijaya, 29: 149–156.

Girmenia, C., Assistant, Department of Haematology, Azienda Policlinico Umberto I, Rome, Menichetti, F., dan Head, Infectious Diseases Unit, Azienda Ospedaliero-Universitaria Pisana, Pisa, 2011. Current Epidemiology and Prevention of Infectious Complications in Cancer Patients. European Oncology & Haematology, 07: 270–277.

Hakim, L., 2012. Farmakokinetika Klinik, Farmasi Klinis. Bursa Ilmu, Yogyakarta.

Labreche, M.J., Lee, G.C., Attridge, R.T., Mortensen, E.M., Koeller, J., Du, L.C., dkk., 2013. Treatment Failure and Costs in Patients With Methicillin-Resistant Staphylococcus aureus (MRSA) Skin and Soft Tissue Infections: A South Texas Ambulatory Research Network (STARNet) Study. The Journal of the American Board of Family Medicine, 26: 508–517.

Lambert, M., 2011. IDSA Guidelines on the Treatment of MRSA Infections in Adults and Children 84: 455–463.

Nathwani, D., 2005. Tigecycline: clinical evidence and formulary positioning. International Journal of Antimicrobial Agents, 25: 185–192.

Pomorska-Wesołowska, M., Różańska, A., Natkaniec, J., Gryglewska, B., Szczypta, A., Dzikowska, M., dkk., 2017. Longevity and gender as the risk factors of methicillin-resistant Staphylococcus aureus infections in southern Poland. BMC Geriatrics, 17: 1–7.

Putra, M.I.H., Suwarto, S., Loho, T., dan Abdullah, M., 2017. Faktor Risiko Methicillin Resistant Staphylococcus aureus pada Pasien Infeksi Kulit dan Jaringan Lunak di Ruang Rawat Inap. Jurnal Penyakit Dalam Indonesia, 1: 3–13.

Sjahril, R. dan Agus, R., 2018. Deteksi Methicillin Resistant Staphylococcus aureus (MRSA) Pada Pasien Rumah Sakit Universitas Hasanuddin Dengan Metode Kultur 7.

Stenstrom, R., Grafstein, E., Romney, M., Fahimi, J., Harris, D., Hunte, G., dkk., 2009. Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus skin and soft tissue infection in a Canadian emergency department. CJEM, 11: 430–438.

Yusuf, Y., Murni, I.K., dan Setyati, A., 2017. Irrational use of antibiotics and clinical outcomes in children with pneumonia. Paediatrica Indonesiana, 57: 211–215.

Zabielinski, M., McLeod, M.P., Aber, C., Izakovic, J., dan Schachner, L.A., 2013. Trends and Antibiotic Susceptibility Patterns of Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus in an Outpatient Dermatology Facility. JAMA Dermatology, 149: 427–432.

DOI: https://doi.org/10.22146/farmaseutik.v16i2.48025